文献速递心血管MR

定量心包延迟强化可提示复发性心包炎的临床病程

Quantitative Pericardial Delayed Hyperenhancement Informs Clinical Course in Recurrent Pericarditis.
PubMed 文献 · JACC Cardiovasc Imaging · 2017-03-15

本研究为回顾性队列研究,纳入159例复发性心包炎患者,通过心脏磁共振短轴延迟强化序列定量评估心包炎症(以正常室间隔心肌为参考,量化高于参考6个标准差以上的心包信号)。中位随访23个月期间20%患者达到临床缓解,较低的定量心包延迟强化与临床缓解独立相关(HR 0.77),且可增加对复发时间和复发率的预后信息。

要点

  • 定量心包延迟强化较低与复发性心包炎临床缓解独立相关(HR 0.77,95%CI 0.64-0.93,P=0.008)。
  • 定量心包延迟强化在临床和实验室变量基础上提供增量预后价值(IDI 8%,NRI 36%)。
  • 定量心包延迟强化较高的患者后续复发时间更短(P=0.012),6个月复发率更高(P=0.026)。

核心结论

  • 复发性心包炎患者定量心包延迟强化与临床结局相关,并提供关于临床病程的增量信息。

研究设计与样本

  • 回顾性队列研究,纳入159例复发性心包炎患者,均接受心包延迟强化成像且随访超过6个月;在短轴延迟强化序列上勾画心包轮廓,以正常室间隔心肌为参考区域,量化高于参考6个标准差以上的心包信号。

关键影像表现/征象

  • 心包延迟强化在复发性心包炎急性期后可能持续存在,提示持续的心包炎症。

诊断标准与关键数值

  • 定量心包延迟强化定义为短轴延迟强化序列上高于正常室间隔心肌参考信号6个标准差以上的心包信号。
  • 较低的定量心包延迟强化与临床缓解独立相关(HR 0.77,95%CI 0.64-0.93,P=0.008)。
  • 定量心包延迟强化在基线临床和实验室变量基础上提供增量预后价值(IDI 8%,NRI 36%)。
  • 定量心包延迟强化较高的患者后续复发时间更短(P=0.012),6个月复发率更高(P=0.026)。

临床应用与阅片要点

  • 定量心包延迟强化可用于复发性心包炎患者的风险分层,较低值提示更可能达到临床缓解。
  • 定量心包延迟强化较高提示后续复发时间更短、6个月复发率更高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The aim of this study was to evaluate the prognostic value of quantitative assessment of pericardial delayed hyperenhancement (DHE) among patients with recurrent pericarditis (RP).

BACKGROUND: Pericardial DHE on cardiac magnetic resonance may persist beyond the acute phase of pericarditis, suggesting continued pericardial inflammation.

METHODS: This is a retrospective cohort study of 159 patients with RP who underwent DHE imaging and had a follow-up period of more than 6 months. Pericardial inflammation was quantified on short-axis DHE sequences by contouring the pericardium, selecting normal septal myocardium as a reference region, and then quantifying the pericardial signal that was >6 SD above the reference. Our primary outcome was clinical remission; secondary outcomes were time to recurrence and recurrence rate.

RESULTS: The mean age of our patients was 46 ± 14 years, and 52% were women. During a median follow-up period of 23 months (interquartile range: 15 to 34 months), 32 (20%) patients achieved clinical remission. In the multivariable Cox proportional hazards model, lower quantitative pericardial DHE (hazard ratio: 0.77; 95% confidence interval: 0.64 to 0.93; p = 0.008) was independently associated with clinical remission. When added to background clinical and laboratory variables, quantitative pericardial DHE had incremental prognostic value over baseline clinical and laboratory variables (integrated discrimination improvement: 8%; net reclassification improvement: 36%). Furthermore, patients with a higher quantitative DHE had shorter time to subsequent recurrence (p = 0.012) and had a higher recurrence rate at 6 months (p = 0.026).

CONCLUSIONS: Quantitative assessment of pericardial DHE was associated with clinical outcomes among patients with RP and provided incremental information regarding the clinical course of patients with RP.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Kumar A, Sato K, Yzeiraj E, et al. Quantitative Pericardial Delayed Hyperenhancement Informs Clinical Course in Recurrent Pericarditis. JACC Cardiovasc Imaging. 2017. PMID: 28330665. doi:10.1016/j.jcmg.2016.10.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。